‘Chief bluebird’ Nick Leschly nails a rich $24M compensation bounty as biotech packages soar
Biotech execs reaped a rich harvest of compensation packages for 2018, and as of now bluebird bio CEO Nick Leschly holds the top mark on pay.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
